Coronavirus Vaccine Candidates for COVID-19

novel-coronavirus-landscape-covid-19cf1952c105464714aaaf8c7cd5c5cc8b

Click on above and you can then click on each Vaccine Candidate that has information available about it…below is a quick glance at what is on it and which Vaccine is where in as Pre-Clinical, Phase I, Phase II, or Phase III of Trials.  In the ABSTRACTS I am reading, it appears that there is a similarity of adverse affects with the Vaccines that may include things such as these-Fever, Shot Site Pain, Joint Pain, Fatigue, and Headaches.  Some are Reports that LACK enough information to understand what it is happening with them in ways I cannot understand.  But, there’s a lot to read for sure and hopefully, you will get a SAFE Vaccine.

DRAFT landscape of COVID-19 candidate vaccines –
24 July 2020
25 candidate vaccines in clinical evaluation
Platform Type of
candidate
vaccine
Developer Coronavirus
target
Current stage of clinical
evaluation/regulatory statusCoronavirus candidate
Same platform for
non-Coronavirus
candidates
Inactivated Inactivated +
alum
Sinovac SARS-CoV2 Phase 3
NCT04456595
Phase 1/2
NCT04383574
NCT04352608
SARS
Inactivated Inactivated Wuhan Institute of
Biological
Products/Sinopharm
SARS-CoV2 Phase 3
ChiCTR2000034780
Phase 1/2
ChiCTR2000031809
Inactivated Inactivated Beijing Institute of
Biological
Products/Sinopharm
SARS-CoV2 Phase 3
ChiCTR2000034780
Phase 1/2
ChiCTR2000032459
NonReplicating
Viral Vector
ChAdOx1-S University of
Oxford/AstraZeneca
SARS-CoV2 Phase 3
ISRCTN89951424
Phase2b/3
2020-001228-32
Phase 1/2
PACTR202006922165132
2020-001072-15
MERS, influenza,
TB, Chikungunya,
Zika, MenB, plague
NonReplicating
Viral Vector
Adenovirus Type
5 Vector
CanSino Biological
Inc./Beijing Institute of
Biotechnology
SARS-CoV2 Phase 2
ChiCTR2000031781
Phase 1
ChiCTR2000030906
Ebola
Protein
Subunit
Adjuvanted
recombinant
protein (RBDDimer)
Anhui Zhifei Longcom
Biopharmaceutical/
Institute of Microbiology,
Chinese Academy of
Sciences
SARS-CoV2 Phase 2
NCT04466085
Phase 1
NCT04445194
MERS
RNA LNPencapsulated
mRNA
Moderna/NIAID SARS-CoV2 Phase 3 (not yet recruiting)
NCT04470427
Phase 2
NCT04405076
Phase 1
NCT04283461
multiple candidates
DNA DNA plasmid
vaccine with
electroporation
Inovio Pharmaceuticals/
International Vaccine
Institute
SARS-CoV2 Phase 1/2
NCT04447781
NCT04336410
multiple candidates
DNA DNA plasmid
vaccine +
Adjuvant
Osaka University/ AnGes/
Takara Bio
SARS-CoV2 Phase 1/2
NCT04463472
DNA DNA Vaccine
(GX-19)
Genexine Consortium SARS-CoV2 Phase 1/2
NCT04445389
DNA DNA plasmid
vaccine
Cadila Healthcare Limited SARS-CoV2 Phase 1/2
CTRI/2020/07/026352

Inactivated Whole-Virion
Inactivated
Bharat Biotech SARS-CoV2 Phase 1/2
CTRI/2020/07/026300
Inactivated Inactivated Institute of Medical Biology
, Chinese Academy of
Medical Sciences
SARS-CoV2 Phase 1/2
NCT04470609
Phase 1
NCT04412538
Protein
Subunit
Full length
recombinant
SARS CoV-2
glycoprotein
nanoparticle
vaccine
adjuvanted with
Matrix M
Novavax SARS-CoV2 Phase 1/2
NCT04368988
RSV; CCHF, HPV,
VZV, EBOV
Protein
Subunit
RBD-based Kentucky Bioprocessing,
Inc
SARS-CoV2 Phase 1/2
NCT04473690
RNA 3 LNP-mRNAs BioNTech/Fosun
Pharma/Pfizer
SARS-CoV2 Phase 1/2
2020-001038-36
NCT04368728
ChiCTR2000034825
RNA mRNA Arcturus/Duke-NUS SARS-CoV2 Phase 1/2
NCT04480957
multiple candidates
NonReplicating
Viral Vector
Adeno-based Gamaleya Research
Institute
SARS-CoV2 Phase 1
NCT04436471
NCT04437875
Protein
Subunit
Native like
Trimeric subunit
Spike Protein
vaccine
Clover Biopharmaceuticals
Inc./GSK/Dynavax
SARS-CoV2 Phase 1
NCT04405908
HIV, REV Influenza
Protein
Subunit
Recombinant
spike protein
with Advax™
adjuvant
Vaxine Pty Ltd/Medytox SARS-CoV2 Phase 1
NCT04453852
Protein
Subunit
Molecular clamp
stabilized Spike
protein with
MF59 adjuvant
University of
Queensland/CSL/Seqirus
SARS-CoV2 Phase 1
ACTRN12620000674932p
Nipah, influenza,
Ebola, Lassa
RNA LNP-nCoVsaRNA Imperial College London SARS-CoV2 Phase 1
ISRCTN17072692
EBOV; LASV, MARV,
Inf (H7N9), RABV
RNA mRNA Curevac SARS-CoV2 Phase 1
NCT04449276
RABV, LASV, YFV;
MERS, InfA, ZIKV,
DENV, NIPV
RNA mRNA People’s Liberation Army
(PLA) Academy of Military
Sciences/Walvax Biotech.
SARS-CoV2 Phase 1
ChiCTR2000034112
VLP Plant-derived
VLP adjuvanted
with GSK or
Dynavax adjs.
Medicago Inc. SARS-CoV2 Phase 1
NCT04450004
Flu, Rotavirus,
Norovirus, West
Nile virus, Cancer
Platform Type of candidate
vaccine
Developer Coronavirus
target
Current stage of clinical
evaluation/regulatory
status- Coronavirus
candidate
Same platform
for nonCoronavirus
candidates
DNA DNA vaccine Ege University SARS-CoV2 Pre-Clinical
DNA DNA plasmid vaccine
RBD&N
Scancell/University of Nottingham/
Nottingham Trent University
SARS-CoV2 Pre-Clinical

DNA DNA plasmid vaccine
S,S1,S2,RBD &N
National Research Centre, Egypt SARS-CoV2 Pre-Clinical
DNA DNA with
electroporation
Karolinska Institute / Cobra
Biologics
(OPENCORONA Project)
SARS-CoV2 Pre-Clinical
DNA DNA with
electroporation
Chula Vaccine Research Center SARS-CoV2 Pre-Clinical
DNA DNA Takis/Applied DNA
Sciences/Evvivax
SARS-CoV2 Pre-Clinical
DNA Plasmid DNA, NeedleFree Delivery
Immunomic Therapeutics,
Inc./EpiVax, Inc./PharmaJet
SARS-CoV2 Pre-Clinical SARS
DNA DNA vaccine BioNet Asia SARS-CoV2 Pre-Clinical
DNA msDNA vaccine Mediphage Bioceuticals/University
of Waterloo
SARS-CoV2 Pre-Clinical
DNA DNA vaccine Entos Pharmaceuticals SARS-CoV2 Pre-Clinical
DNA bacTRL-Spike Symvivo SARS-CoV2 Pre-Clinical
Inactivated Inactivated + alum KM Biologics SARS-CoV2 Pre-Clinical JE, Zika
Inactivated Inactivated Selcuk University SARS-CoV2 Pre-Clinical
Inactivated Inactivated Erciyes University SARS-CoV2 Pre-Clinical
Inactivated Inactivated whole
virus
National Research Centre, Egypt SARS-CoV2 Pre-Clinical
Inactivated Inactivated Beijing Minhai Biotechnology Co.,
Ltd.
SARS-CoV2 Pre-Clinical
Inactivated TBD Osaka University/ BIKEN/ NIBIOHN SARS-CoV2 Pre-Clinical
Inactivated Inactivated + CpG
1018
Sinovac/Dynavax SARS-CoV2 Pre-Clinical
Inactivated Inactivated + CpG
1018
Valneva/Dynavax SARS-CoV2 Pre-Clinical
Inactivated Inactivated Research Institute for Biological
Safety Problems, Rep of Kazakhstan
SARS-CoV2 Pre-Clinical
Live
Attenuated
Virus
Codon deoptimized
live attenuated
vaccines
Mehmet Ali Aydinlar University /
Acıbadem Labmed Health Services
A.S.
SARS-CoV2 Pre-Clinical
Live
Attenuated
Virus
Codon deoptimized
live attenuated
vaccines
Codagenix/Serum Institute of India SARS-CoV2 Pre-Clinical HAV, InfA, ZIKV,
FMD, SIV, RSV,
DENV
Live
Attenuated
Virus
Codon deoptimized
live attenuated
vaccines
Indian Immunologicals Ltd/Griffith
University
SARS-CoV2 Pre-Clinical
NonReplicating
Viral Vector
Sendai virus vector ID Pharma SARS-CoV2 Pre-Clinical
NonReplicating
Viral Vector
Adenovirus-based Ankara University SARS-CoV2 Pre-Clinical
NonReplicating
Viral Vector
Adeno-associated
virus vector
(AAVCOVID)
Massachusetts Eye and
Ear/Massachusetts General
Hospital/AveXis
SARS-CoV2 Pre-Clinical
NonReplicating
Viral Vector
MVA encoded VLP GeoVax/BravoVax SARS-CoV2 Pre-Clinical LASV, EBOV,
MARV, HIV
NonReplicating
Viral Vector
Ad26 Janssen Pharmaceutical Companies SARS-CoV2 Pre-Clinical Ebola, HIV, RSV
NonReplicating
Viral Vector
Replication defective
Simian Adenovirus
(GRAd) encoding
SARS-CoV-2 S
ReiThera/LEUKOCARE/Univercells SARS-CoV2 Pre-Clinical
Nonreplicating
viral vector
MVA-S encoded DZIF – German Center for Infection
Research/IDT Biologika GmbH
SARS-CoV2 Pre-clinical Many
Nonreplicating
viral vector
MVA-S IDIBAPS-Hospital Clinic, Spain SARS-CoV2 Pre-clinical
NonReplicating
Viral Vector
adenovirus-based
NasoVAX expressing
Altimmune SARS-CoV2 Pre-Clinical influenza

SARS2-CoV spike
protein
NonReplicating
Viral Vector
Adeno5-based Erciyes University SARS-CoV2 Pre-Clinical
NonReplicating
Viral Vector
2nd Gen E2b- Ad5
Spike, RBD,
Nucleocapsid
Subcutaneous&Oral
ImmunityBio, Inc. & NantKwest,
Inc.
SARS-CoV2 Pre-Clinical flu, Chik, Zika,
EBOV, LASV,
HIV/SIV,Cancer
NonReplicating
Viral Vector
Ad5 S (GREVAX™
platform)
Greffex SARS-CoV2 Pre-Clinical MERS
NonReplicating
Viral Vector
Oral Ad5 S Stabilitech Biopharma Ltd SARS-CoV2 Pre-Clinical Zika, VZV, HSV-2
and Norovirus
NonReplicating
Viral Vector
adenovirus-based +
HLA-matched
peptides
Valo Therapeutics Ltd Pan-Corona Pre-Clinical
NonReplicating
Viral Vector
Oral Vaccine platform Vaxart SARS-CoV2 Pre-Clinical InfA, CHIKV,
LASV, NORV;
EBOV, RVF, HBV,
VEE
NonReplicating
Viral Vector
MVA expressing
structural proteins
Centro Nacional Biotecnología
(CNB-CSIC), Spain
SARS-CoV2 Pre-Clinical Multiple
candidates
NonReplicating
Viral Vector
Dendritic cell-based
vaccine
University of Manitoba SARS-CoV2 Pre-Clinical
NonReplicating
Viral Vector
parainfluenza virus 5
(PIV5)-based vaccine
expressing the spike
protein
University of Georgia/University of
Iowa
SARS-CoV2 Pre-Clinical MERS
NonReplicating
Viral Vector
Recombinant
deactivated rabies
virus containing S1
Bharat Biotech/Thomas Jefferson
University
SARS-CoV2 Pre-Clinical HeV, NiV, EBOV,
LASSA, CCHFV,
MERS
NonReplicating
Viral Vector
Influenza A H1N1
vector
National Research Centre, Egypt SARS-CoV2 Pre-Clinical
NonReplicating
Viral Vector
Inactivated Flu-based
SARS-CoV2 vaccine +
Adjuvant
National Center for Genetic
Engineering and Biotechnology
(BIOTEC) /GPO, Thailand
SARS-CoV2 Pre-Clinical
Protein
Subunit
RBD-protein Mynvax SARS-CoV2 Pre-Clinical
Protein
Subunit
Recombinant S
protein
Izmir Biomedicine and Genome
Center
SARS-CoV2 Pre-Clinical
Protein
Subunit
Peptide + novel
adjuvant
Bogazici University SARS-CoV2 Pre-Clinical
Protein
Subunit
S subunit intranasal
liposomal formulation
with GLA/3M052 adjs.
University of Virginia SARS-CoV2 Pre-Clinical
Protein
Subunit
S-Protein (Subunit) +
Adjuvant, E coli based
Expression
Helix Biogen Consult, Ogbomoso &
Trinity Immonoefficient
Laboratory, Ogbomoso, Oyo State,
Nigeria.
SARS-CoV2 Pre-Clinical
Protein
Subunit
Protein Subunit
S,N,M&S1 protein
National Research Centre, Egypt SARS-CoV2 Pre-Clinical
Protein
Subunit
Protein Subunit University of San Martin and
CONICET, Argentina
SARS-CoV2 Pre-Clinical
Protein
Subunit
RBD protein fused
with Fc of IgG + Adj.
Chulalongkorn University/GPO,
Thailand
SARS-CoV2 Pre-Clinical
Protein
Subunit
Capsid-like Particle AdaptVac (PREVENT-nCoV
consortium)
SARS-CoV2 Pre-Clinical
Protein
Subunit
Drosophila S2 insect
cell expression system
VLPs
ExpreS2ion SARS-CoV2 Pre-Clinical
Protein
Subunit
Peptide antigens
formulated in LNP
IMV Inc SARS-CoV2 Pre-Clinical

Protein
Subunit
S protein WRAIR/USAMRIID SARS-CoV2 Pre-Clinical
Protein
Subunit
S protein +Adjuvant National Institute of Infectious
Disease, Japan/Shionogi/UMN
Pharma
SARS-CoV2 Pre-Clinical Influenza
Protein
Subunit
VLP-recombinant
protein + Adjuvant
Osaka University/ BIKEN/ National
Institutes of Biomedical Innovation,
Japan
SARS-CoV2 Pre-Clinical
Protein
Subunit
microneedle arrays S1
subunit
Univ. of Pittsburgh SARS-CoV2 Pre-Clinical MERS
Protein
Subunit
Peptide Vaxil Bio SARS-CoV2 Pre-Clinical
Protein
Subunit
Adjuvanted protein
subunit (RBD)
Biological E Ltd SARS-CoV2 Pre-Clinical
Protein
Subunit
Peptide Flow Pharma Inc SARS-CoV2 Pre-Clinical Ebola, Marburg,
HIV, Zika,
Influenza, HPV
therapeutic
vaccine,
BreastCA
vaccine
Protein
Subunit
S protein AJ Vaccines SARS-CoV2 Pre-Clinical
Protein
Subunit
Ii-Key peptide Generex/EpiVax SARS-CoV2 Pre-Clinical Influenza, HIV,
SARS-CoV
Protein
Subunit
S protein EpiVax/Univ. of Georgia SARS-CoV2 Pre-Clinical H7N9
Protein
Subunit
Protein Subunit EPVCoV-19
EpiVax SARS-CoV2 Pre-Clinical
Protein
Subunit
S protein (baculovirus
production)
Sanofi Pasteur/GSK SARS-CoV2 Pre-Clinical Influenza, SARSCoV
Protein
Subunit
gp-96 backbone Heat Biologics/Univ. Of Miami SARS-CoV2 Pre-Clinical NSCLC, HIV,
malaria, Zika
Protein
Subunit
Peptide vaccine FBRI SRC VB VECTOR,
Rospotrebnadzor, Koltsovo
SARS-CoV2 Pre-Clinical Ebola
Protein
Subunit
Subunit vaccine FBRI SRC VB VECTOR,
Rospotrebnadzor, Koltsovo
SARS-CoV2 Pre-Clinical
Protein
Subunit
S1 or RBD protein Baylor College of Medicine SARS-CoV2 Pre-Clinical SARS
Protein
Subunit
Subunit protein, plant
produced
iBio/CC-Pharming SARS-CoV2 Pre-Clinical
Protein
Subunit
Recombinant protein,
nanoparticles (based
on S-protein and
other epitopes)
Saint-Petersburg scientific research
institute of vaccines and serums
SARS-CoV2 Pre-Clinical
Protein
Subunit
COVID-19 XWG-03
truncated S (spike)
proteins
Innovax/Xiamen Univ./GSK SARS-CoV2 Pre-Clinical HPV
Protein
Subunit
Adjuvanted
microsphere peptide
VIDO-InterVac, University of
Saskatchewan
SARS-CoV2 Pre-Clinical
Protein
Subunit
Synthetic Long
Peptide Vaccine
candidate for S and M
proteins
OncoGen SARS-CoV2 Pre-Clinical
Protein
Subunit
Oral E. coli-based
protein expression
system of S and N
proteins
MIGAL Galilee Research Institute SARS-CoV2 Pre-Clinical
Protein
Subunit
Nanoparticle vaccine LakePharma, Inc. SARS-CoV2 Pre-Clinical
Protein
Subunit
Plant-based subunit
(RBD-Fc + Adjuvant)
Baiya Phytopharm/ Chula Vaccine
Research Center
SARS-CoV2 Pre-Clinical
Protein
Subunit
OMV-based vaccine Quadram Institute Biosciences SARS-CoV2 Pre-Clinical Flu A, plague
Protein
Subunit
OMV-based vaccine BiOMViS Srl/Univ. of Trento SARS-CoV2 Pre-Clinical
Protein
subunit
structurally modified
spherical particles of
Lomonosov Moscow State
University
SARS-CoV2 Pre-Clinical rubella,
rotavirus

the tobacco mosaic
virus (TMV)
Protein
Subunit
Spike-based University of Alberta SARS-CoV2 Pre-Clinical Hepatitis C
Protein
Subunit
Recombinant S1-Fc
fusion protein
AnyGo Technology SARS-CoV2 Pre-Clinical
Protein
Subunit
Recombinant protein Yisheng Biopharma SARS-CoV2 Pre-Clinical
Protein
Subunit
Recombinant S
protein in IC-BEVS
Vabiotech SARS-CoV2 Pre-Clinical
Protein
Subunit
Orally delivered, heat
stable subunit
Applied Biotechnology Institute,
Inc.
SARS-CoV2 Pre-Clinical
Protein
Subunit
S-2P protein + CpG
1018
Medigen Vaccine Biologics
Corporation/NIAID/Dynavax
SARS-CoV2 Pre-Clinical
Protein
Subunit
Peptides derived from
Spike protein
Axon Neuroscience SE SARS-CoV2 Pre-Clinical
Protein
Subunit
Protein Subunit MOGAM Institute for Biomedical
Research, GC Pharma
SARS-CoV2 Pre-Clinical
Protein
Subunit
RBD-based Neovii/Tel Aviv University SARS-CoV2 Pre-Clinical
Protein
Subunit
Outer Membrane
Vesicle (OMV)-subunit
Intravacc/Epivax SARS-CoV2 Pre-Clinical
Protein
Subunit
Outer Membrane
Vesicle(OMV)-peptide
Intravacc/Epivax SARS-CoV2 Pre-Clinical
Protein
Subunit
Spike-based (epitope
screening)
ImmunoPrecise/LiteVax BV SARS-CoV2 Pre-Clinical
Replicating
Viral Vector
YF17D Vector KU Leuven SARS-CoV2 Pre-Clinical
Replicating
Viral Vector
Measles Vector Cadila Healthcare Limited SARS-CoV2 Pre-Clinical
Replicating
Viral Vector
Measles Vector Institute Pasteur/Themis/Univ. of
Pittsburg Center for Vaccine
Research/Merck
SARS-CoV2 Pre-Clinical West nile, chik,
Ebola, Lassa,
Zika
Replicating
Viral Vector
Measles Vector FBRI SRC VB VECTOR,
Rospotrebnadzor, Koltsovo
SARS-CoV2 Pre-Clinical
Replicating
Viral Vector
Measles Virus (S, N
targets)
DZIF – German Center for Infection
Research/CanVirex AG
SARS-CoV2 Pre-clinical Zika, H7N9,
CHIKV
Replicating
Viral Vector
Horsepox vector
expressing S protein
Tonix Pharma/Southern Research SARS-CoV2 Pre-Clinical Smallpox,
monkeypox
Replicating
Viral Vector
Live viral vectored
vaccine based on
attenuated influenza
virus backbone
(intranasal)
BiOCAD and IEM SARS-CoV2 Pre-Clinical Influenza
Replicating
Viral Vector
Recombinant vaccine
based on Influenza A
virus, for the
prevention of COVID19 (intranasal)
FBRI SRC VB VECTOR,
Rospotrebnadzor, Koltsovo
SARS-CoV2 Pre-Clinical Influenza
Replicating
Viral Vector
Attenuated Influenza
expressing
an antigenic portion
of the Spike protein
Fundação Oswaldo Cruz and
Instituto Buntantan
SARS-CoV2 Pre-Clinical Influenza
Replicating
Viral Vector
Influenza vector
expressing RBD
University of Hong Kong SARS-CoV2 Pre-Clinical
Replicating
Viral Vector
Replicationcompetent VSV
chimeric virus
technology (VSVΔG)
delivering the SARSCoV-2 Spike (S)
glycoprotein.
IAVI/Merck SARS-CoV2 Pre-Clinical Ebola, Marburg,
Lassa
Replicating
Viral Vector
VSV-S University of Western Ontario SARS-CoV2 Pre-Clinical HIV, MERS
Replicating
Viral Vector
VSV-S Aurobindo SARS-CoV2 Pre-Clinical
Replicating
Viral Vector
VSV vector FBRI SRC VB VECTOR,
Rospotrebnadzor, Koltsovo
SARS-CoV2 Pre-Clinical

Replicating
Viral Vector
VSV-S Israel Institute for Biological
Research/Weizmann Institute of
Science
SARS-CoV2 Pre-Clinical
Replicating
Viral Vector
M2-deficient single
replication (M2SR)
influenza vector
UW–Madison/FluGen/Bharat
Biotech
SARS-CoV2 Pre-Clinical influenza
Replicating
Viral Vector
Newcastle disease
virus vector (NDVSARS-CoV-2/Spike)
Intravacc/ Wageningen
Bioveterinary Research/Utrecht
Univ.
SARS-CoV2 Pre-Clinical
Replicating
Viral Vector
Avian paramyxovirus
vector (APMV)
The Lancaster University, UK SARS-CoV2 Pre-Clinical
RNA Self-amplifying RNA Gennova SARS-CoV2 Pre-Clinical
RNA mRNA Selcuk University SARS-CoV2 Pre-Clinical
RNA LNP-mRNA Translate Bio/Sanofi Pasteur SARS-CoV2 Pre-Clinical
RNA LNP-mRNA CanSino Biologics/Precision
NanoSystems
SARS-CoV2 Pre-Clinical
RNA LNP-encapsulated
mRNA cocktail
encoding VLP
Fudan University/ Shanghai
JiaoTong University/RNACure
Biopharma
SARS-CoV2 Pre-Clinical
RNA LNP-encapsulated
mRNA encoding RBD
Fudan University/ Shanghai
JiaoTong University/RNACure
Biopharma
SARS-CoV2 Pre-Clinical
RNA Replicating Defective
SARS-CoV-2 derived
RNAs
Centro Nacional Biotecnología
(CNB-CSIC), Spain
SARS-CoV2 Pre-Clinical
RNA LNP-encapsulated
mRNA
University of Tokyo/ Daiichi-Sankyo SARS-CoV2 Pre-Clinical MERS
RNA Liposomeencapsulated mRNA
BIOCAD SARS-CoV2 Pre-Clinical
RNA Several mRNA
candidates
RNAimmune, Inc. SARS-CoV2 Pre-Clinical
RNA mRNA FBRI SRC VB VECTOR,
Rospotrebnadzor, Koltsovo
SARS-CoV2 Pre-Clinical
RNA mRNA China CDC/Tongji
University/Stermina
SARS-CoV2 Pre-Clinical
RNA LNP-mRNA Chula Vaccine Research
Center/University of Pennsylvania
SARS-CoV2 Pre-Clinical
RNA mRNA in an intranasal
delivery system
eTheRNA SARS-CoV2 Pre-Clinical
RNA mRNA Greenlight Biosciences SARS-CoV2 Pre-Clinical
RNA mRNA IDIBAPS-Hospital Clinic, Spain SARS-CoV2 Pre-Clinical
VLP VLP Bezmialem Vakif University SARS-CoV2 Pre-Clinical
VLP VLP Middle East Technical University SARS-CoV2 Pre-Clinical
VLP Enveloped Virus-Like
Particle (eVLP)
VBI Vaccines Inc. SARS-CoV-2,
SARS-CoV,
& MERSCoV
Pre-Clinical CMV, GBM, Zika
VLP S protein integrated in
HIV VLPs
IrsiCaixa AIDS Research/IRTACReSA/Barcelona Supercomputing
Centre/Grifols
SARS-CoV2 Pre-Clinical
VLP VLP + Adjuvant Mahidol University/ The
Government Pharmaceutical
Organization (GPO)/Siriraj Hospital
SARS-CoV2 Pre-Clinical
VLP Virus-like particles,
lentivirus and
baculovirus vehicles
Navarrabiomed, Oncoimmunology
group
SARS-CoV2 Pre-Clinical
VLP Virus-like particle,
based on RBD
displayed on virus-like
particles
Saiba GmbH SARS-CoV2 Pre-Clinical

VLP ADDomerTM
multiepitope display
Imophoron Ltd and Bristol
University’s Max Planck Centre
SARS-CoV2 Pre-Clinical
VLP Unknown Doherty Institute SARS-CoV2 Pre-Clinical
VLP VLP OSIVAX SARS-CoV1
SARS-CoV2
Pre-Clinical
VLP eVLP ARTES Biotechnology SARS-CoV2 Pre-Clinical malaria
VLP VLPs peptides/whole
virus
Univ. of Sao Paulo SARS-CoV2 Pre-Clinical
Unknown Unknown Tulane University SARS-CoV2 Pre-Clinical

DISCLAIMER:
These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020 pandemic of the
novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be deemed or construed as, any
approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes reasonable steps to verify the accuracy of the
information presented in these landscape documents, WHO does not make any (and hereby disclaims all) representations and warranties regarding the accuracy,
completeness, fitness for a particular purpose (including any of the aforementioned purposes), quality, safety, efficacy, merchantability and/or non-infringement of any
information provided in these landscape documents and/or of any of the products referenced therein. WHO also disclaims any and all liability or responsibility
whatsoever for any death, disability, injury, suffering, loss, damage or other prejudice of any kind that may arise from or in connection with the procurement,
distribution or use of any product included in any of these landscape documents.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.